Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...

KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or ...

Should you start taking your allergy medicine now? We VERIFY the answer to that and other common questions about allergy treatments.